EP. 1: Prostate Cancer Disease Complexity and Testing
Neal Shore, MD, discusses the complexity of prostrate cancer and factors to consider when determining management strategies.
EP. 2: Genotypic and Phenotypic Biomarkers in Prostate Cancer
A discussion of phenotypic and genotypic biomarkers found in prostate cancer and their implications.
EP. 3: Diagnostic and Therapeutic Applications of PSMA in Prostate Cancer
An overview of the diagnostic and therapeutic applications of PSMA in prostate cancer is presented.
EP. 4: Use of PSMA PET Scans in Advanced Prostate Cancer
Dr Neal Shore explains the clinical implications of PSMA PET scans in advanced prostate cancer.
EP. 5: The VISION Study of 177Lu-PSMA-617 in mCRPC
Results of the phase 3 VISION study of 177Lu-PSMA PET in advanced prostate cancer are described.
EP. 6: Future Directions With PSMA Ligand–Directed Therapies
Highlights of potential future applications of PSMA ligand–directed therapies in prostate cancer.
Breast Cancer Index Risk Scores Are Prognostic for Premenopausal Women With HR+ Breast Cancer Receiving Adjuvant Endocrine Therapy
Black Women With HR+ Breast Cancer Have Worse Outcomes, Despite Similar Recurrence Scores
Benefit of Adjuvant Abemaciclib Increases at 4-Year monarchE Landmark Analysis for Patients With HR+/HER2– High-Risk Early Breast Cancer
Everolimus Plus Adjuvant Endocrine Therapy Fails to Improve iDFS, OS in HR+/HER2- Breast Cancer
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.